Ventiv price target raised by Jefferies

Ventiv Health Inc. was maintained by Jefferies & Co. analyst David Windley at a buy rating and the price target on the stock was raised to $30 per share from $29 following news of its acquisition of inChord Communications for $185 million. Ventiv shares Thursday were up $1.27, or 5.15%, at $25.91 on volume of 894,010 shares versus the three-month running average of 444,346 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.